|
Device | FoundationOne Liquid CDx (F1 Liquid CDx) |
Generic Name | Next generation sequencing oncology panel, somatic or germline variant detection system |
Applicant | Foundation Medicine, Inc. 150 Second Street Cambridge, MA 02141 |
PMA Number | P200006 |
Supplement Number | S003 |
Date Received | 09/30/2022 |
Decision Date | 10/28/2022 |
APCB Date
|
05/26/2023 |
Product Code |
PQP |
Advisory Committee |
Pathology |
Supplement Type | Normal 180 Day Track No User Fee |
Supplement Reason | Postapproval Study Protocol |
Expedited Review Granted? | No |
Combination Product | No |
Approval Order Statement Approval for the termination of the post-approval study (PAS) protocol. |